Guozhen Tan
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Indole-3-Lactic Acid Attenuates IMQ-Induced Psoriasiform Dermatitis in Mice via AhR-Dependent Suppression of IL-17A.
Journal: Psoriasis (Auckland, N.Z.)
Published: December 15, 2025
Serum Neuropeptides in Chronic Spontaneous Urticaria: Associations With Disease Activity and Clinical Phenotypes.
Journal: Allergy, asthma & immunology research
Published: July 26, 2025
Neutrophil/Lymphocyte Ratio as a Biomarker of Response to H1-Antihistamine Therapy in Patients with Chronic Spontaneous Urticaria.
Journal: Indian journal of dermatology
Published: December 09, 2024
Metformin Treatment Protects Mice from Glucose-Promoted Psoriasiform Dermatitis through Enrichment of Akkermansia muciniphila with Modulation of Bacterial Tryptophan Metabolites.
Journal: The Journal of investigative dermatology
Published: March 20, 2024
Topical treatment of tyrosine kinase 2 inhibitor through borneol-embedded hydrogel: Evaluation for preventive, therapeutic, and Recurrent management of psoriasis.
Journal: Bioactive materials
Published: November 02, 2023
Decreased HMGCS1 inhibits proliferation and inflammatory response of keratinocytes and ameliorates imiquimod-induced psoriasis via the STAT3/IL-23 axis.
Journal: International immunopharmacology
Published: October 24, 2023
Cytotoxic CD161-CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosus.
Journal: EBioMedicine
Published: October 27, 2022
Profiling Serum Cytokines and Anticytokine Antibodies in Psoriasis Patients.
Journal: Journal of immunology research
Published: May 01, 2022
Anti-galectin-3 antibodies induce skin vascular inflammation via promoting local production of IL-1β in systemic lupus erythematosus.
Journal: International immunopharmacology
Published: April 06, 2022
CD19+CD24highCD27+ B cell and interleukin 35 as potential biomarkers of disease activity in systemic lupus erythematosus patients.
Journal: Advances in rheumatology (London, England)
Published: October 12, 2021
ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils.
Journal: Frontiers in immunology
Published: May 25, 2021
Last Updated: 09/26/2026